In contrast, the free ICG group presented no fluorescence signals in the tumor site (Figure 5A, bottom panel), demonstrating that FAP-2286-ICG could predominantly improve the tumor-targeting ability and possess longer tumor retention behavior. The gene discussed is FAP; the disease is neoplasm.